-
By Drew Armstrong, Bloomberg |
November 1, 2012
Pfizer Inc., the world’s biggest drugmaker, narrowed its 2012 forecast after reporting third- quarter earnings that met analyst estimates and sales that fell short of expectations.
-
By Rita Nazareth, Bloomberg |
October 23, 2012
U.S. stocks fell, sending the Dow Jones Industrial Average toward its biggest loss since June, amid disappointing results at companies from 3M Co. to DuPont Co. and as commodities erased their gain for the year.
-
By Marvin G. Perez, Bloomberg |
April 10, 2012
Orange-juice futures plunged to a 17-month low as speculators unwound bullish bets and U.S. consumer demand dwindled.
-
By Tom Schoenberg, Bloomberg |
March 5, 2012
A U.S. Food and Drug Administration chemist was sentenced to five years in prison for using his access to the agency’s drug-approval process to make $3.78 million in an insider-trading scheme.
-
By Phil Flynn |
January 10, 2012
Daily energy fundamentals from Phil Flynn
-
By Canaccord Genuity Morning Coffee |
June 27, 2011
Pharmaceutical companies, such as Pfizer, are scrambling to develop new products as patents are approaching expiration
